Eight Drugs a Week Podcast6 Okt 2022

Immunosuppressive drugs TDM: It's getting better! "Getting better"

In our inaugural episode of Eight Drugs a Week we are very lucky to be joined by two former IATDMCT Presidents, Loralie Langman and Pierre Marquet. Both are very well known for their work with immunosuppressant drugs, particularly in the context of transplantation.

In this episode we talk about:

Planning the ideal immunosuppressant monitoring program in solid organ transplant recipients

Why France is ahead of the curve in immunosuppressant TDM

Why a particular mycophenolate TDM RCT is the 'poster study' for TCI in the TCI vs TDM debate

Lessons learned in microsampling using DBS and VAMs for immunosuppressant monitoring

Eight Drugs a Week is supported by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). The personal views of the hosts and guests do not necessarily reflect the position of the Association.

To join IATDMCT, visit https://www.iatdmct.org/member-join

Subscribe to Eight Drugs a Week on your preferred podcast platform.

About our guests:

Loralie Langman is one of the Directors of the Clinical and Forensic Toxicology Laboratory at the Mayo Clinic, Rochester, Minnesota, as well as a Consultant for the Personalized Genomics Laboratory. She is Professor of Laboratory Medicine and Pathology at the Mayo Clinic College of Medicine.

Pierre Marquet is Professor of Pharmacology at the Medical School, University of Limoges, France. He heads the pharmacology-toxicology department at Limoges University Hospital and is director of the research unit "Pharmacology and Transplantation".

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(20)

Eight Drugs a Week Episode 18 – Rennes 2026: Day Tripper… Moving from Legend to Reality 🙌

What do Arthurian legend, a medieval convent, and the future of precision medicine have in common? They all converge in Rennes, France this September - and if this episode is anything to go by, the IA...

16 Mai 20min

Fixing a Hole: Using TDM to Address Medication Non-Adherence

Adherence to medication is the very basic level we wish to reach in patient care. Yet for many patients taking drugs every day (sometimes several times a day, over long periods of time, this is far fr...

2 Mar 26min

Tuberculosis drugs TDM: The long and winding road

Tuberculosis remains one of the world's most persistent infectious diseases, and despite decades of available treatments, achieving cure remains a long and winding road. The challenge isn't just the d...

6 Jan 34min

Revolution 9: How the microbiome is evolving our understanding of drug disposition

The human microbiome, a complex community of bacteria, fungi, protozoa, and viruses, doesn't just passively coexist with the drugs we take; it actively participates in a bidirectional relationship tha...

31 Okt 202526min

IATDMCT annual meeting in Singapore. I've got a meeting (I've got a feeling)

We gather the two chairs of the upcoming IATDMCT annual meeting in Singapore, Sophie Stocker and Jana Stojanova, plus Cindy Lau, who contribute to the organization of the young scientists' part of the...

16 Jul 202527min

IATDMCT annual meeting in Singapore. I've got a meeting (I've got a feeling)

16 Jul 202527min

Pharmacogenetics: Here, There and Everywhere

Pharmacogenetics now surrounds us and is an efficient tool to prevent disease or to guide drug therapy. By studying polymorphisms in the genes coding for metabolism enzymes and drug transporters, we c...

7 Nov 202421min

TDM for beta-lactams in critical care: You know my name (Look up the number)

Given we traditionally only monitored particular antibiotics to spare toxicity, and that beta lactams were widely considered such safe drugs, it was once difficult to imagine this drug class would bec...

13 Aug 202437min